New heart valve tested for severe aortic stenosis
NCT ID NCT06680427
Summary
This early study is testing a new device called the Siegel TAVR system for people with severe, symptomatic aortic stenosis. It aims to see if the device is safe and works well when implanted without open-heart surgery. The study will enroll about 30 adults who are eligible for this type of valve replacement procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS SYMPTOMATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Atlantic Health System
Morristown, New Jersey, 07960, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90071, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Columbia University Medical Center/ NYPH
New York, New York, 10032, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
NCH Healthcare System
Naples, Florida, 34102, United States
-
Piedmont Healthcare
Atlanta, Georgia, 30309, United States
-
Stanford
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.